You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 8, August 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Pediatrics, Other
 •Obesity
 •Alert me on articles by topic

Development of Novel Medications for Use in the Treatment of Obesity in Children Will Be Directed by Delineating Controls of Energy Homeostasis

Arch Pediatr Adolesc Med. 2003;157:721.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THIS ISSUE of the ARCHIVES highlights the current pandemic of obesity, and its resultant complications, in children and adolescents. What is to be done about this alarming situation? Clearly, there is no single easy answer to a complex matter that likely has multiple etiologic risk factors.

Future attention must be paid to both the prevention and treatment of childhood obesity. However, as many will know from personal experience, it is not clear what are the most appropriate interventions. Even very small discrepancies in energy intake will result, in the long run, in excess weight gain.1 Reduced intake, increased exercise, and the changes in lifestyle that are advocated to achieve these goals are difficult—if not impossible—for many to maintain for protracted periods of time.

For many, the concept of a medication taken either to suppress appetite or encourage satiety holds attraction as an alternate approach for the prevention and treatment of . . . [Full Text of this Article]

Philip M. Sherman, MD, FRCPC
Research Institute
Hospital for Sick Children
University of Toronto
555 University Ave
Toronto, Ontario
Canada M5G 1X8
(e-mail: philip.sherman@sickkids.on.ca)

Stanley H. Zlotkin, MD, PhD, FRCPC
Toronto







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.